Trade CANF stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) (CANF) is trading at US$1.90, down 5.00% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$7.13M. Over the past 52 weeks, CANF has traded between US$0.17 and US$10.40. On Syfe you can trade CANF with $0 commission and add it to your watchlist.
| Previous close | US$2.00 |
|---|---|
| Market cap | US$7.13M |
| 52-week range | US$0.17 – US$10.40 |
| Volume | 32.07K |
| Exchange | US |
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Year: 2012
Top Midday Decliners
Sep 2, 6:03 PM · MT Newswires
Can-Fite BioPharma Announces $4 Million Warrant Exercise
Sep 2, 1:26 PM · MT Newswires
Can-Fite BioPharma Files $100 Million Shelf
Aug 28, 8:37 PM · MT Newswires
Can-Fite BioPharma Completes Enrollment in Phase 3 Study of Potential Plaque Psoriasis Treatment
Jul 6, 11:46 AM · MT Newswires
Sector Update: Healthcare Stocks Higher Late Afternoon
Jul 1, 7:48 PM · MT Newswires
Stay on top of CANF
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
